Homologous recombination deficiency (HRD) testing on cell-free tumor DNA from peritoneal fluid
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Homologous recombination deficiency (HRD) testing on cell-free tumor DNA from peritoneal fluid
Authors
Keywords
-
Journal
Molecular Cancer
Volume 22, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-11-06
DOI
10.1186/s12943-023-01864-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working Group
- (2022) J. Pascual et al. ANNALS OF ONCOLOGY
- A Randomized, Phase III Trial to Evaluate Rucaparib Monotherapy as Maintenance Treatment in Patients With Newly Diagnosed Ovarian Cancer (ATHENA–MONO/GOG-3020/ENGOT-ov45)
- (2022) Bradley J. Monk et al. JOURNAL OF CLINICAL ONCOLOGY
- Circulating tumour DNA — looking beyond the blood
- (2022) Ann Tivey et al. Nature Reviews Clinical Oncology
- Cell-free DNA is abundant in ascites and represents a liquid biopsy of ovarian cancer
- (2021) Bonnita Werner et al. GYNECOLOGIC ONCOLOGY
- Clinical Implications of Circulating Tumor DNA from Ascites and Serial Plasma in Ovarian Cancer
- (2020) Mi-Ryung Han et al. Cancer Research and Treatment
- ShallowHRD: detection of homologous recombination deficiency from shallow whole genome sequencing
- (2020) Alexandre Eeckhoutte et al. BIOINFORMATICS
- Epithelial ovarian cancer
- (2019) Stephanie Lheureux et al. LANCET
- Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
- (2019) Antonio González-Martín et al. NEW ENGLAND JOURNAL OF MEDICINE
- Veliparib with First-Line Chemotherapy and as Maintenance Therapy in Ovarian Cancer
- (2019) Robert L. Coleman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer
- (2019) Isabelle Ray-Coquard et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ovarian cancer statistics, 2018
- (2018) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Next-generation sequencing reveals mutational accordance between cell-free DNA from plasma, malignant pleural effusion and ascites and directs targeted therapy in a gastric cancer patient
- (2018) Shujuan Zhou et al. CANCER BIOLOGY & THERAPY
- Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
- (2018) Kathleen Moore et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cell-Free DNA from Ascites and Pleural Effusions: Molecular Insights into Genomic Aberrations and Disease Biology
- (2017) Hatim Husain et al. MOLECULAR CANCER THERAPEUTICS
- Origins, structures, and functions of circulating DNA in oncology
- (2016) A. R. Thierry et al. CANCER AND METASTASIS REVIEWS
- Homologous Recombination Deficiency: Exploiting the Fundamental Vulnerability of Ovarian Cancer
- (2015) P. A. Konstantinopoulos et al. Cancer Discovery
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started